Cover Image
市場調查報告書

中國的動物疫苗產業的相關調查研究

In-depth Research on China Animal Vaccine Industry, 2014

出版商 Huidian Research 商品編碼 259889
出版日期 內容資訊 英文 101 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
中國的動物疫苗產業的相關調查研究 In-depth Research on China Animal Vaccine Industry, 2014
出版日期: 2014年02月24日 內容資訊: 英文 101 Pages
簡介

根據中國動物用醫藥品協會(CVDA)的統計,2012年中國的活性減毒疫苗生產能力,為3445億8千萬份,非活性疫苗的生產能力為553億9200萬毫升。同年,中國的動物疫苗產業年度銷售額達到88億8800萬人民幣,前10名企業佔了生物產品整體銷售額的50%。

本報告提供中國的動物疫苗產業的環境,技術開發,產業的發展,競爭情形,主要企業等等,為您概述為以下內容。

第1章 中國的動物疫苗產業發展環境

  • 市場特性
    • 產業定義
    • 產業特徵
  • 經濟環境
    • 經濟開發情形
    • 國內整體生產(GDP)
    • 固定資產投資
    • 進出口額和成長率
  • 政策環境
    • 產業相關政策
    • 相關政策效果

第2章 中國動物疫苗產業的技術開發

  • 產品技術的成熟度
  • 中國和外國之間的技術差距和主要理由
  • 中國的技術提高的策略

第3章 中國的動物疫苗產業的發展

  • 豬隻疫苗
  • 家禽疫苗
  • 寵物疫苗

第4章 動物疫苗產業的經濟活動

  • 產業的生產·銷售
  • 產業規模
  • 產業的收益
  • 產業的產業開發能力
  • 產業的債務付款能力

第5章 中國的動物疫苗的進出口

  • 進口
  • 出口

第6章 中國投資的產業競爭情形影響

  • 中國的動物疫苗產業的邁克爾·波特五力分析
    • 現有企業間的競爭
    • 潛在的新加入廠商者
    • 替代品
    • 供應商談判力
    • 客戶談判力
  • 中國的動物疫苗產業競爭展望
  • 中國的動物疫苗產業競爭預測

第7章 國內的主要企業

第8章 動物的疫苗產業的投資分析

  • 投資機會
  • 投資風險
    • 政策風險
    • 市場風險
    • 應用程式的風險
    • 技術風險
  • 進入的產業障礙
    • 進入的行政上障礙
    • 技術障礙
    • 品牌障礙
    • 管理障礙
    • 金融障礙
  • 產業投資提案

第9章 投資機會及動物疫苗產業的風險

  • 中國的動物疫苗產業的投資機會
    • 投資機會
    • 可行性調查
  • 動物的疫苗產業的投資效率
    • 運用情形
    • 投資效率
    • 投資趨勢預測
    • 投資新人教育

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄

At present, there are 88 animal vaccine manufacturers in China, with 338 production lines. But most of enterprises are small in scale, vaccine production inspection is not standard and product structures are not reasonable. Market shares are occupied by a minority of enterprises.

According to the statistics by China Veterinary Drug Association (CVDA), the production capacity of live vaccines was 344.58 billion doses in 2012; the production capacity of inactivated vaccines was 55.392 billion milliliters; in China's animal vaccine industry, the annual sales revenue reached CNY 8.888 billion in 2012, and the top 10 enterprises as for sales revenue accounted for 50% of total sales revenue of biological products.

Among the key animal vaccine manufacturers in China in 2012, China Animal Husbandry Industry Co., Ltd (CAHIC) obtained the most business income registering CNY 1.17 billion, accounting for 13.16% market share. TECON, Dahuanong, Jinyu Group and Ringpu also had more than 5% market share respectively.

According to the survey by Huidian Research, the growth of China's animal vaccine market was slowing down in 2013, it was estimated that year-on-year growth was about 15% and the market scale reached CNY 10.22 billion in 2013, of which, swine vaccine accounted for 50% shares and poultry vaccine accounted for 36%.

Table of Contents

1. Development Environment of China's Animal Vaccine Industry

  • 1.1. Market Characteristics
    • 1.1.1. Industry Definition
    • 1.1.2. Industry Characteristics
  • 1.2. Economic Environment
  • 1.3. Policy Environment
    • 1.3.1. Industry Related Policy
    • 1.3.2. Influence of Related Policy

2. Technology Development of China's Animal Vaccine Industry

  • 2.1. Product Technology Maturity
  • 2.2. Technology Gap between China and Foreign Countries and Main Reasons
  • 2.3. Strategy for Improving China's Technology

3. Development of China's Animal Vaccine Industry

  • 3.1. Swine Vaccine
  • 3.2. Poultry Vaccines
  • 3.3. Pet Vaccines

4. Economic Operation of Animal Vaccine Industry

  • 4.1. Industry Production and Sales in 2012
  • 4.2. Industry Scale, 2008-2013
  • 4.3. Industry Profit in 2012
  • 4.4. Industry Profitability in 2012
  • 4.5. Industry Business Development Capacity in 2012
  • 4.6. Industry Debt Paying Ability in 2012

5. Import and Export of China's Animal Vaccine

  • 5.1. Import
  • 5.2. Export

6. Effect of Industry Competition Landscape on Investment in China, 2013

  • 6.1. Porter Five Forces Analysis of China's Animal Vaccine Industry
    • 6.1.1. Competition between the Existing Enterprises
    • 6.1.2. Potential New Entrant
    • 6.1.3. Substitute
    • 6.1.4. Bargaining Power of Supplier
    • 6.1.5. Bargaining Power of Customers
  • 6.2. Competition Landscape of China's Animal Vaccine Industry
  • 6.3. Competition Forecast of China's Animal Vaccine Industry

7. Domestic Key Enterprises, 2013

  • 7.1. China Animal Husbandry Industry Co., Ltd. (CAHIC)
    • 7.1.1. Company Profile
    • 7.1.2. Business Performance
    • 7.1.3. Company Competitiveness
    • 7.1.4. Development Strategy
  • 7.2. Qingdao Yebio Bioengineering Co., Ltd.
    • 7.2.1. Company Profile
    • 7.2.2. Business Performance
    • 7.2.3. Company Competitiveness
  • 7.3. Guangdong Dahuanong Animal Health Products Co. Ltd.
    • 7.3.1. Company Profile
    • 7.3.2. Business Performance
    • 7.3.3. Company Competitiveness
    • 7.3.4. Development Strategy
  • 7.4. TECON
    • 7.4.1. Company Profile
    • 7.4.2. Business Performance
    • 7.4.3. Company Competitiveness
    • 7.4.4. Development Strategy
  • 7.5. Inner Mongolia Jinyu Group Stock Company
    • 7.5.1. Company Profile
    • 7.5.2. Business Performance
    • 7.5.3. Company Competitiveness
    • 7.5.4. Development Strategy
  • 7.6. Tianjin Ringpu Bio-technology Co., Ltd.
    • 7.6.1. Company Profile
    • 7.6.2. Business Performance
    • 7.6.3. Marketing Channel
  • 7.7. Chengdu TECBOND Biological Products Co., Ltd.
    • 7.7.1. Company Profile
    • 7.7.2. Business Performance
    • 7.7.3. Competitiveness
    • 7.7.4. Development Strategy

8. Investment Analysis of Animal Vaccine Industry, 2014-2018

  • 8.1. Investment Opportunity
  • 8.2. Investment Risk
    • 8.2.1. Policy Risk
    • 8.2.2. Market Risk
    • 8.2.3. Application Risk
    • 8.2.4. Technology Risk
  • 8.3. Industry Barriers to Entry
    • 8.3.1. Administrative Barriers to Entry
    • 8.3.2. Technical Barrier
    • 8.3.3. Brand Barrier
    • 8.3.4. Management Barrier
    • 8.3.5. Capital Barrier
  • 8.4. Industry Investment Proposals

9. Investment Opportunity and Risk of Animal Vaccine Industry

  • 9.1. Investment Opportunity of China's Animal Vaccine Industry
    • 9.1.1. Investment Opportunity
    • 9.1.2. Feasibility Study
  • 9.2. Investment Efficiency of Animal Vaccine Industry
    • 9.2.1. Investment Status
    • 9.2.2. Investment Efficiency
    • 9.2.3. Investment Trend Forecast
    • 9.2.4. Investment Orientation
Back to Top